Join the Izervay group to help and get support from people like you.
Izervay News
FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
WEDNESDAY, Aug. 9, 2023 – The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related...
FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic Atrophy
TOKYO, Aug. 5, 2023 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), today announced the U.S. Food and Drug Administration (FDA) approved Izervay™ (...
Ask a question
To post your own question to this support group, sign in or create an account.